These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Schnitzler syndrome: treatment failure to rituximab but response to anakinra.
    Author: Eiling E, Möller M, Kreiselmaier I, Brasch J, Schwarz T.
    Journal: J Am Acad Dermatol; 2007 Aug; 57(2):361-4. PubMed ID: 17467852.
    Abstract:
    Schnitzler syndrome is a rare disease characterized by a chronic urticarial rash and a monoclonal gammopathy. The exact pathogenesis is still uncertain and treatment remains a challenge. Here, we report a patient who was only recently given the diagnosis of Schnitzler syndrome although the typical symptoms had been present for about 6 years. Administration of the B-cell antibody rituximab did not exert any beneficial effect despite effective elimination of B cells and a reduction of the paraprotein. In contrast, injection of the interleukin-1-receptor antagonist anakinra caused a complete remission within a few days.
    [Abstract] [Full Text] [Related] [New Search]